Patents Assigned to Medical Discovery Partners LLC
  • Publication number: 20160274006
    Abstract: A method and apparatus that serve as a control and calibrator for assays performed on cells and tissues mounted on a microscope slide is described. The apparatus comprises a quality control moiety, such as a peptide epitope, linked to a particulate object, such as a clear spherical bead and the bead is preferably approximately the size of a cell. The quality control moiety is designed to behave in a similar manner in the assay as an analyte, yielding a positive assay reaction an the bead is retained on a microscope slide during the steps of staining by a novel liquid matrix, which solidifies upon drying and causes adherence of the beads to the microscope slide.
    Type: Application
    Filed: November 7, 2014
    Publication date: September 22, 2016
    Applicant: MEDICAL DISCOVERY PARTNERS LLC
    Inventors: Seshi R. Sompuram, Steven A. Bogen
  • Patent number: 8263404
    Abstract: An antigen-dependent negative selection blood cell separation method is described. Rare circulating epithelial cells can be separated from blood by depleting erythrocytes from a blood sample. Erythrocytes are depleted by agglutination. The new method comprises the use of an agglutinating agent, such as an anti-glycophorin A or glycophorin B antibody, as glycophorin A or B are present on erythrocytes and not on the desired epithelial cells. With regular mixing, desired rare circulating epithelial cells do not become entrapped in the red cell agglutinate.
    Type: Grant
    Filed: April 4, 2006
    Date of Patent: September 11, 2012
    Assignee: Medical Discovery Partners LLC
    Inventors: Sarah K. Olken, Steven A. Bogen, Seshi R. Sompuram
  • Publication number: 20090081632
    Abstract: An antigen-dependent negative selection blood cell separation method is described. Rare circulating epithelial cells can be separated from blood by depleting erythrocytes from a blood sample. Erythrocytes are depleted by agglutination. The new method comprises the use of an agglutinating agent, such as an anti-glycophorin A or glycophorin B antibody, as glycophorin A or B are present on erythrocytes and not on the desired epithelial cells. With regular mixing, desired rare circulating epithelial cells do not become entrapped in the red cell agglutinate.
    Type: Application
    Filed: April 4, 2006
    Publication date: March 26, 2009
    Applicant: Medical Discovery Partners LLC
    Inventors: Sarah K. Olken, Steven A. Bogen, Seshi R. Sompuram
  • Patent number: 7011940
    Abstract: The invention describes quality control devices for assays that measure analytes in cells and tissue samples, and methods of use thereof. In particular, the quality control device comprises a matrix affixed with synthetic controls in different concentrations, or different synthetic controls. The quality control device can be adhered to a microscope slide via an adhesive or chemically attached to a microscope slide and processed simultaneously with a tissue sample.
    Type: Grant
    Filed: April 14, 2000
    Date of Patent: March 14, 2006
    Assignee: Medical Discovery Partners LLC
    Inventors: Seshi R. Sompuram, Halasya Ramanathan, Steven A. Bogen
  • Patent number: 6855490
    Abstract: The invention describes a method for attaching biological molecules, such as proteins, nucleic acids, and carbohydrates to a glass surface. In particular, a covalent attachment method is described wherein a glass surface is first activated with a water-stable form of an isocyanate, termed a protected isocyanate. The protecting group of the isocyanate moiety is displaced by amines, hydroxyl, or carboxyl groups of biological molecules, leading to covalent attachment to the glass surface.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: February 15, 2005
    Assignee: Medical Discovery Partners LLC
    Inventors: Seshi R. Sompuram, Halasya Ramanathan